Our Clean Sweep Live Auction is coming up fast! Next Tuesday, September 26th at 9:30AM EST

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment


Oncology Homepage

ASTRO Product Showcase Some of the products and services on display at ASTRO 2017

The future of radiation therapy: Integrated MR guidance Insights from Joel Goldwein, senior vice president of medical affairs at Elekta

Alan Baron Proton Partners International appoints New Board Member

Penn Medicine treats first patient with Varian Halcyon radiation treatment platform Cuts down on time and costs

International Atomic Energy Agency in partnership to get new Varian linac Will help the agency answer requests for standards and guidance

Study finds MR detects 98 percent of pregnancy-related breast cancers May also inform surgical management of disease

Mevion submits MEVION S250i for premarket approval Features improved pencil-beam scanning

Radiology Partners to acquire Southwest Diagnostic Imaging Joining with SDI 'represents about a 25 percent increase' in RP's size

Q&A with Brian Kavanagh ASTRO president Find out what to expect at this year's meeting and what plans are in place for the coming year

Laparoscopic surgery for pancreatic cancer offers shorter hospital stays than open surgery But the procedure takes longer

Precision medicine is having a big impact on breast cancer chemo decisions: study

by Lauren Dubinsky , Senior Reporter
While the concept of precision medicine still has a futuristic ring to it, researchers at the University of Michigan are showing how physicians in everyday practice can use biomarker tests to make significantly more personalized decisions regarding which breast cancer patients may require chemotherapy to ensure recurrence doesn't happen, and which patients are probably better off without.

"The idea of precision medicine is to give patients the treatments that are the most likely to help and avoid needless side effects," Christopher Friese, study author and professor at the University of Michigan School of Nursing, said in a statement.

Story Continues Below Advertisement

qualiTEE - reliabiliTEE - repairabiliTEE - we guaranTEE

Bayer HealthCare Multi Vendor Service will repair your transducer with the same precision and care you provide to your patients. Now offering TotalREPAIR on 140 transducer models! Call us at 1-844-5100 or visit www.mvs.bayer.com to set up an order today.

The test is called the 21-gene recurrence score assay (RS) and it looks at 21 genes that are known to increase the risk of cancer recurrence. The goal is to avoid chemotherapy in patients who are at low risk because they most likely won’t benefit from it and to make sure that chemotherapy is recommended for women at high risk.

The researchers surveyed 3,880 women who were treated for breast cancer in 2013 and 2014 in California and Georgia. A total of 1,527 patients with early-stage breast cancer responded to the survey and 778 received the test.

They found that 47.2 percent of the patients with RS scores received a recommendation against chemotherapy and 40.6 percent received a recommendation for it. Those results correlated with the professional guideline recommendations.

However, they did find that about 13 percent of the patients whose lymph nodes were positive for breast cancer were given the test — even though there’s no evidence they would have benefitted from the test or the outcome.

The researchers evaluated registry and laboratory data and found that 60 percent of the patients accurately recalled receiving the test.

"This suggests that while precision medicine for breast cancer has left the station, we have left a few women behind," said Friese. "There's opportunity in the oncology community to improve how we explain to women the purpose of these tests, how to interpret the results, and what the results mean for their breast cancer treatment."

In addition, almost two-thirds thought the test was helpful in shifting their opinion for or against chemotherapy.

Oncology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.